Stratos Wealth Partners’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Stratos Wealth Partners’s Portfolio OREX Stock Details OREX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-170	Closed	–	–	3195
2018 Q1	$0	Hold	170	–	–	﹤0.01%	3345
2017 Q4	$0	Buy	+170	New	+$277	﹤0.01%	2882

Other funds holding OREX

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Stratos Wealth Partners's OREX Position: Q2 2018 in Review

Stratos Wealth Partners sold out of Orexigen Therapeutics, Inc. (OREX) in Q2 2018, closing a stake of 170 shares.

Stratos Wealth Partners first reported a position in OREX in Q4 2017 and held it in 2 quarters. The position peaked at $0 in Q1 2018. 4 funds tracked by Wall St. Rank hold OREX as of Q2 2018.

Stratos Wealth Partners reported no remaining Orexigen Therapeutics, Inc. position as of Q2 2018 after selling out during the quarter.
Stratos Wealth Partners sold 170 Orexigen Therapeutics, Inc. shares in Q2 2018.
Stratos Wealth Partners first reported a position in Orexigen Therapeutics, Inc. in Q4 2017 and held it in 2 quarters.
Stratos Wealth Partners's Orexigen Therapeutics, Inc. position peaked at $0 in Q1 2018.
4 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q2 2018.

Based on Stratos Wealth Partners's 13F filing for Q2 2018, filed 13 Aug 2018.